Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$42.05 - $47.77 $2,102 - $2,388
-50 Reduced 0.49%
10,114 $440,000
Q1 2022

May 12, 2022

SELL
$40.23 - $47.74 $7,040 - $8,354
-175 Reduced 1.69%
10,164 $443,000
Q3 2021

Nov 03, 2021

BUY
$38.79 - $43.16 $19,201 - $21,364
495 Added 5.03%
10,339 $395,000
Q2 2021

Aug 02, 2021

BUY
$36.52 - $41.46 $4,930 - $5,597
135 Added 1.39%
9,844 $392,000
Q1 2021

Apr 28, 2021

BUY
$34.27 - $40.01 $3,427 - $4,001
100 Added 1.04%
9,709 $347,000
Q4 2020

Feb 02, 2021

BUY
$34.07 - $39.94 $18,738 - $21,967
550 Added 6.07%
9,609 $354,000
Q3 2020

Oct 28, 2020

SELL
$38.11 - $42.99 $1,524 - $1,719
-40 Reduced 0.44%
9,059 $341,000
Q2 2020

Jul 23, 2020

BUY
$37.87 - $43.58 $7,384 - $8,498
195 Added 2.19%
9,099 $371,000
Q1 2020

Apr 27, 2020

SELL
$32.47 - $48.83 $811 - $1,220
-25 Reduced 0.28%
8,904 $337,000
Q4 2019

Jan 31, 2020

BUY
$42.0 - $48.25 $5,880 - $6,755
140 Added 1.59%
8,929 $420,000
Q3 2019

Oct 31, 2019

BUY
$40.46 - $43.52 $12,057 - $12,968
298 Added 3.51%
8,789 $375,000
Q2 2019

Jul 26, 2019

SELL
$39.4 - $42.7 $1,576 - $1,708
-40 Reduced 0.47%
8,491 $340,000
Q1 2019

Apr 30, 2019

SELL
$38.57 - $42.69 $73,283 - $81,111
-1,900 Reduced 18.21%
8,531 $357,000
Q4 2018

Feb 08, 2019

SELL
$37.8 - $42.69 $567 - $640
-15 Reduced 0.14%
10,431 $398,000
Q3 2018

Oct 22, 2018

BUY
$39.75 - $42.69 $10,732 - $11,526
270 Added 2.65%
10,446 $419,000
Q2 2018

Jul 23, 2018

SELL
$39.61 - $42.76 $11,288 - $12,186
-285 Reduced 2.72%
10,176 $410,000
Q1 2018

Apr 26, 2018

BUY
$36.18 - $40.15 $1,736 - $1,927
48 Added 0.46%
10,461 $409,000
Q4 2017

Jan 23, 2018

SELL
$35.34 - $41.9 $21,416 - $25,391
-606 Reduced 5.5%
10,413 $370,000
Q3 2017

Oct 26, 2017

BUY
$39.44 - $41.55 $434,589 - $457,839
11,019
11,019 $448,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Delta Asset Management LLC Portfolio

Follow Delta Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Asset Management LLC with notifications on news.